JNJ vs XMTR · P/E 17, rev $49.37B vs rev $434.4M
Johnson & Johnson (JNJ) versus Xometry Inc (XMTR) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Xometry Inc (XMTR) is a industrial distribution company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported XMTR revenue for 2026-06-30 was $434.4M. Net income was -$10.6M. XMTR currently screens at market cap $4.81B.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. XMTR currently screens at market cap $4.81B.
Not investment advice. Open the JNJ and XMTR stock pages for the full models.
Not investment advice.